INTRODUCTION
Mouse embryonic stem cells (ES) derived from the inner cell mass (ICM) stage of embryogenesis retain their totipotency in vivo and in vitro (Gossler et al., 1986; Doetschman et al., 1987; Thompson et al., 1989; Koller and Smithies, 1989; Schwartzberg et al., 1989; Zijlstra et al., 1989; DeChiara et al., 1990; Koller et al., 1990) . In vitro, ES cells differentiate into endoderm, ectoderm, and mesoderm (Martin and Evans, 1975; Martin, 1977; Robertson, 1987) . The development in vitro of blood island or erythropoietic stem cells equivalent to the yolk sac stage (i.e., day [8] [9] [10] of embryogenesis) has been reported (Doetschman et al., 1985; Gossler et al., 1986; Robertson, 1987) .
Furthermore, erythroid and myeloid lineages containing megakaryocytes were also obtained by Cudennec and Johnson (1981) while studying the differentiation of teratocarcinoma cells in vitro. Recently, the mechanism of developmental regulation of the ]/-globin was studied with ES cells in vitro (Lindenbaum and Grosveld, 1990 ; Wiles and Keller, 1991; Schmitt et al., 1991) .
The origin of the pluripotent stem cells and their lineage commitment'to lymphocytes from mouse embryos are important issues in developmental biology that have recently received much attention. Stem cells from yolk sacs have been shown to give rise to erythrocytes, megakaryotic cells, and myeloid cells (Labastie et al., 1984) . B lymphocytes can also be found after yolk sac stem cells are transferred into animals, but not in in vitro differentiation condition (Melchers, 1977; Paige et al., 1979; Melchers and Abramczuk, 1980 ; Chris Paige, personal communication). On the other hand, stem cells obtained from the fetal liver can give rise to erythroid, myeloid, and B-lymphoid cells in vitro (Owen et al., 1975; Melchers, 1977; Ogawa et al., 1988; Rolink et al., 1991) . Differentiation of T-lymphoid cells requires a thymic microenvironment (see review by von Boehmer, 1990 The liquid culture system described in this study allows the development of pluripotent hematopoietic stem cells and. all known hematopoietic lineages, including lymphoid (T and B) lineages from ES cells. Because this is an important step for studying lymphohematopoiesis in vitro, and because any deviation from the culture condition described in this study did (Martin and Evans, 1975; Cudennec and Nicolas, 1977; Doetschman et al., 1985; Gossler et al., 1986; Robertson, 1987 (Fig. 1) Log fluorescence intensity Log fluorescence intensity (Ozato et al., 1985) . However, ES-cell-derived hematopoietic cells express H-2Kb, Fig. 7(C (Gorman et al., 1985) (Melchers, 1977; Rolink et al., 1991;  F. Melchers, personal communication) .
The IL-2 and IL-7 responsive lymphocytes appear, at the earliest, at day 12-13 during embryogenesis (B. Imhof, personal communication). Adult thymus provides an environment for precursor cells to mature into intrathymic precursor cells that express mature T-cell marker CD4 (Wu et al., 1991) . Fetal thymus appears earliest at day 10 of mouse embryogenesis and colonization by precursor stem cells is 1 day later, and parallels the development of fetal liver. The findings of IL-2-and IL-7-responsive lymphocytes and single CD4 cells from ES fetuses and the establishment of the CD3 obTCR+, CD4-CD8-T-cell clone suggest that either ES fetuses provide thymus-equivalent environment or thymic environment is not neces- sary for the maturation of these cells. The culture conditions described in this paper seem to be favorable for the development of lymphocytes equivalent to these stages. Genetic manipulation of mouse ES cells (Thompson et al., 1989; Mansour et al., 1988; Koller and Smithies, 1989 ) and germ-line transmission of a specific defect (Schwartzberg et Robertson, 1987, p.74, for detailed procedure). The screening of FCS requires a positive control lot of FCS for comparison, and (b) they are supportive in the splenic lymphoid cell culture system of Mishell and Dutton (1967) and are classified as "good FCS" by the Mishell's nomenclature (see Shiigi and Mishell, 1975; Mishell et al., 1978 (Martin and Evans, 1975) (Gossler et al., 1986; Robertson, 1987) (Koo and Peppard, 1984) ; G-5-2, which recognizes GP-76 on Pre-B and plasma cells (Strasser, 1988) (Dennert et al., 1980) ; GK1.5, which recognizes CD4 molecules on T cells (Wilde et al., 1983 ); 53-6-75, which recongizes CD8 molecules on T cells (Ledbetter and Herzenberg, 1979) ; H57-597, which recognizes all ob T-cell receptors (Kubo et al., 1989) (Accepted August 7, 1991) 
